InvestorNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Releases Letter to Stockholders
April 6, 2022
Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety, published a letter to its stockholders from CEO David Palach. “We achieved multiple significant milestones in 2021, successfully transitioning Save Foods from a research and development focused organization to a commercial […]
InvestorNewsBreaks – South Star Battery Metals Corp. (TSX.V: STS) (OTCQB: STSBF) Announces ‘Next Cornerstone’ Toward World-Class Graphite Production
April 5, 2022
South Star (TSX.V: STS) (OTCQB: STSBF) has announced its entry into a binding streaming agreement with Sprott Resource Streaming and Royalty Corp (“SRSR”) for a total cash consideration of up to US$28 million as prepayment for graphite concentrates from the Santa Cruz Graphite Project in Brazil. According to the announcement, South Star will act as […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Enrolls First Patient in PCS12852 Phase 2A Trial
April 5, 2022
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet medical needs, today announced that it has enrolled its first patient in the Phase 2A clinical trial of PCS12852 in patients with moderate to severe gastroparesis. A chronic gastric motility disorder in which […]
InnerScope Hearing Technologies Inc. (INND) Seeks to Position for the Launch of the OTC Hearing Aid Law; Inks Agreement with RiteAid.Com
April 5, 2022
InnerScope Hearing Technologies recently announced that subsidiary HearingAssist’s products would be carried by RiteAid.com The distribution agreement with one of the nation’s leading drug store chains comes as InnerScope seeks to position itself to benefit from the upcoming OTC Hearing Aid Law The Hearing Aid Law will create a new category of hearing aids, available […]
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Doug Heldoorn, Chairman of Advanced Container Technologies Inc.
April 5, 2022
NEW YORK, April 05, 2022 (GLOBE NEWSWIRE) — via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect
April 5, 2022
Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco Shares Company Highlights, Goals at 2022 Virtual Growth Conference Presented by Maxim Group LLC
April 4, 2022
The three-day event showcased CNS through corporate presentation, fireside chat, and live question and answer sessions CNS has been granted both Orphan Drug Designation and Fast Track status from the FDA for Berubicin in 2020 and 2021, respectively CNS initiated a potentially pivotal global trial of Berubicin for recurrent Glioblastoma Multiforme (“GBM”) with the dosing […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Positioned to Expand Portfolio, Capitalize on Growing Demand for Gold
April 1, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) recently entered into a purchase option agreement that gives it exclusive right and option to acquire from Perry English and Gravel Ridge Resources Ltd. (“Optionors”), a 100% dividend interest in the Ranger/Otter mining project located in Red Lake, Ontario. “This agreement opens an opportunity for StraightUp to grow its […]
InvestorNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Inc. Achieves New Milestone
April 1, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that Adelia Therapeutics, a wholly controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as contemplated by the terms of a contribution agreement dated Dec. 4, 2020. The transaction agreement was among Cybin, […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, Full-Year 2021 Financial, Operational Report
April 1, 2022
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, is reporting its financial results and operating highlights for the fourth quarter and full year ended Dec. […]
InvestorNewsBreaks – GreenBox POS (NASDAQ: GBOX) Releases Q4, FY 2021 Financial Report, Operational Highlights
April 1, 2022
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, is reporting financial results for the fourth quarter and full year for the period ended Dec. 31, 2021. Report highlights include record revenue for the company, which totaled $26.3 million for the year; an increase of $17.8 million or 208.6% over the $8.5 million reported in […]
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Call to Review Q4, FY 2021 Financial Results
March 31, 2022
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, has scheduled a conference call to discuss financial results that will be reported today after market close. The financial results will […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Opens Acclaim-2 Clinical Trial for Patient Enrollment
March 31, 2022
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, has announced the opening for patient enrollment of its Acclaim-2 clinical trial. According to the update, Acclaim-2 is an open-label, multi-center phase 1/2 clinical trial evaluating the company’s lead drug candidate, REQORSA(TM) Immunogene Therapy, in combination […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Year-End 2021 Financial, Corporate Results
March 31, 2022
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve survival and/or quality of life, has reported its financial numbers and corporate highlights for 2021 year end. Highlights of the report included the success of the company’s next-generation capecitabine Phase 1B […]
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan
March 31, 2022
RWB’s mission has always been to become the superior and most recognizable cannabis company in the United States It seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitions So far, in 2022, the company has announced the acquisition of PharmaCo, which sees […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition
March 31, 2022
In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as […]
InvestorNewsBreaks – Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) Releases Q4 2021 Financial Report
March 30, 2022
Exro Technologies (TSX.V: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed a new class of power electronics for electric motors and batteries, has reported financial numbers and operational milestones for the fourth quarter 2021. Highlights of the report include the fact that Exro R&D activities increased twofold during 2021 as the company worked […]
Silo Pharma Inc. (SILO) Is ‘One to Watch’
March 30, 2022
Silo recently extended its option with the University of Maryland, Baltimore to explore arthritogenic joint-homing peptides and their use in arthritis-inflamed joints In December 2021, the company announced the issuance of a patent relating to its University of Maryland, Baltimore licensed homing peptide for enhanced targeting of therapeutic agents to the central nervous system The […]
Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Shores Up Food Supply Chain During Disruptive Era, Maintains Revenue Growth Forecast
March 30, 2022
Eat Well Investment Group Inc. is a rapid-growth supplier of nutritious, plant-based food products for people and pets Amid large disruptions to global food security occasioned by the COVID-19 pandemic and war in Ukraine, Eat Well is working to overcome supply chain obstacles to further its mission of supplying the world with nutritious, life-enhancing food […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Significant Milestone Toward Advancing CYB003 Program
March 29, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the completion of in vivo preclinical studies evaluating its deuterated psilocybin analog CYB003 for the potential treatment of major depressive disorder (“MDD”). According to the update, data from the studies demonstrate that CYB003 is well-tolerated following several doses […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Update on Advances in Brain Cancer Drugs and Operational Financials
March 29, 2022
Texas-based CNS Pharmaceuticals is a novel brain cancer drug developer that is building a series of global clinical trials for its lead drug candidate, Berubicin CNS began dosing patients in a global trial last September to evaluate Berubicin in treating glioblastoma multiforme (“GBM”), currently an incurable brain cancer CNS received FDA Fast Track designation for […]
Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast
March 29, 2022
HENC is focusing on expansion of current operations, future growth in industry Company aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”) Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC) strategic business plan and […]
ECGI Approaching Key Strategic Milestones in the Cannabinoid Marketplace
March 29, 2022
LOS ANGELES, March 29, 2022 (GLOBE NEWSWIRE) — via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is pleased to offer current and prospective shareholders with the following update on the Company’s operations. “We are working to […]
InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Expected Report, Strengthened Balance Sheet
March 28, 2022
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, expects to report more than $65 million in cash and cash equivalents when it files Form 10Q for second quarter, the period ending March 31, 2022. The company has made significant progress and taken milestone steps during the quarter, including beginning trading on the Nasdaq […]
InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Finalizes Registered Trademarks in Eight Markets Around the World
March 28, 2022
TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) announced that it has obtained registered trademark status in eight global markets. The company had applied for trademark registration for its TAAT(R) brand name in the United States, the European Union, Australia, New Zealand, the Philippines, Israel, India and Mexico. TAAT began the process of trademark protection […]
InvestorNewsBreaks – StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Focused on Executing 2022 Plans, Including New Acquisitions, Expanded Market Reach
March 25, 2022
StraightUp Resources (CSE: ST) (OTCQB: STUPF) recognizes the issues posed by the Ukraine crisis, which, though focused on Eastern Europe, is affecting various sectors globally. “Despite its properties being located in North America, the developments in Russia and Ukraine, coupled with the former’s sanctions, are affecting its operations and its shareholders’ willingness to take more […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Creating One-of-a-Kind Digital System as NFTs are Set to Transform Music Industry
March 25, 2022
Hollywall Entertainment (OTC: HWAL), an innovative telecommunications and broadcasting company, understands the inherent value of non-fungible tokens (“NFTs”), which are poised to transform the music industry by facilitating equitable compensation for artists and enhancing the potential for remixes and collaborations. The company also understands that NFTs are becoming an integral part of how fans can […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone Outlined in Contribution Agreement
March 25, 2022
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved a key milestone. The milestones were identified in the Dec. 4, 2020, contribution agreement between Cybin and Adelia and include Year 1 Q4 (vi), Year 2 Q2 (ii), Year […]
Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia
March 25, 2022
Cannabis product cultivator Flora Growth Corp. operates a premium growing facility in central Colombia and has received a growing list of authorizations to export its cannabis products for varied health and wellness purposes Flora Growth’s authorized distribution of low-THC CBD cannabis derivatives has been recently expanded to include a quota of up to 43,600 kg […]
Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic
March 25, 2022
Following the acquisition of KWC back in November 2021, Delic Holdings Corp set out to open additional state-of-the-art ketamine infusion treatment clinics over the course of 18 months The company has just announced the opening of its second clinic in Nevada in a move that will serve both local patients and those in larger California […]
InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) Calls Validation of Discovery 21 Proof-of-Concept Campaign a ‘Key Milestone’
March 24, 2022
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it had reached a key milestone toward monetizing its unique approach to leverage AI in oncology drug discovery. The company noted that earlier this year its proprietary Discovery 21 proof-of-concept campaign showed the ability […]
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Participate at Maxim Group 2022 Virtual Growth Conference
March 24, 2022
VistaGen (NASDAQ: VTGN), a late clinical-stage, neuro-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, today announced that its Chief Executive Officer Shawn Singh will participate in a fireside chat with Maxim Analyst Jason McCarthy, Ph.D. The chat is slated to take […]
InvestorNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Refiles Restated OTC Market Filings, Releases Corporate Update
March 24, 2022
Golden Triangle Ventures (OTC: GTVH), multifaceted, vertically integrated entity with businesses in CBD, entertainment, food/beverage and technologies, has completed what it calls “a significant milestone.” The company announced that it had finished the full restatement of all 11 financial statements that were issued from June 30, 2019, through Dec. 31, 2021. The company has also again […]
InvestorNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces IRB Approval for Planned Smoking Cessation Study
March 24, 2022
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has received conditional approval from the Institutional Review Board (“IRB”) for its planned multisite phase 2b smoking cessation trial. According to the announcement, Johns Hopkins University will serve as the lead investigational site for […]
Golden Triangle Ventures, Inc. Announces Completion of Its Restated OTC Markets Filings and Provides Corporate Update
March 24, 2022
LAS VEGAS, March 24, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) announces that it has completed a significant milestone by obtaining Pink Current Information through the full restatement of all 11 financial statements that were issued from June 30, 2019, through Dec. 31, 2021. […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference Call to Discuss Q4 2021 Results, Provide Clinical Pipeline Update
March 23, 2022
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet medical need conditions, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on March 30, 2022, to discuss its fourth quarter 2021 results and provide an […]
InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Initiates Enrollment for Study to Evaluate TRP-8802 to Treat Binge Eating Disorder
March 23, 2022
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced the first patient enrolled to evaluate its clinical candidate, TRP-8802, in a clinical trial. The study will be conducted in collaboration with the University of Florida and will investigate the safety and preliminary […]
InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Flagship Product Now Available in More than 2,500 Retail Locations
March 23, 2022
TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has reached a milestone. The company announced that TAAT(TM), its tobacco-free and nicotine-free alternative to traditional cigarettes, is on the shelves of more than 2,500 retail stores throughout the United States. The company launched the product in Ohio in December 2020, and as of January 2022, the […]
Friendable Inc. (FDBL) Reaches over 111,000 Artist Sign-Ups; Gets Featured by XLIVE Publication
March 23, 2022
Following the acquisition of online music distribution company Artist Republik, Friendable has created a 360-degree platform that nurtures independent artists without the constraints of a label Fan Pass Live Artist Pro-Services provide artists more options for branding and exposure The company has launched merchandise for Spring 2022 for artists and fans, releasing new styles that […]
InvestorNewsBreaks – Exro Technologies Inc.’s (TSX: EXRO) (OTCQB: EXROF) Coil Driver(TM) Shown to Improve Electric Motorcycle Performance, Enhance Efficiencies
March 22, 2022
Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean technology company that has developed a new class of power electronics for electric motors and batteries, today announced completion of side-by-side testing using Exro’s 100 Volt Coil Driver and Zero Motorcycles’ OE premium electric powertrain. According to the update, the results validate Coil Driver’s performance in […]